Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Dublin 2
SEC filing record 1 source field available
Fiscal year end
31 December
AVADEL PHARMACEUTICALS PLC has filed 1,174 SEC EDGAR filings since 14 Feb 1997

SEC filing history

Showing 551-575 of 981 matching filings.

Per page
25
Current page
23
8-K File 001-37977

8-K

Filing date
11 Jan 2018
Reporting date
11 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37977

8-K

Filing date
02 Jan 2018
Reporting date
02 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

FORM 4/A

Filing date
19 Dec 2017
Reporting date
15 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
19 Dec 2017
Reporting date
15 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
14 Dec 2017
Reporting date
12 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
14 Dec 2017
Reporting date
12 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
14 Dec 2017
Reporting date
12 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
14 Dec 2017
Reporting date
12 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
14 Dec 2017
Reporting date
12 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
11 Dec 2017
Reporting date
07 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37977

FORM 8-K

Filing date
08 Dec 2017
Reporting date
08 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
29 Nov 2017
Reporting date
27 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q/A File 001-37977

FORM 10-Q/A

Filing date
17 Nov 2017
Reporting date
30 Sep 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37977

8-K

Filing date
13 Nov 2017
Reporting date
13 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-50223

SCHEDULE 13G

Filing date
09 Nov 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37977

8-K

Filing date
08 Nov 2017
Reporting date
08 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
11 Oct 2017
Reporting date
10 Oct 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
11 Oct 2017
Reporting date
10 Oct 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
11 Oct 2017
Reporting date
10 Oct 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
11 Oct 2017
Reporting date
10 Oct 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
11 Oct 2017
Reporting date
10 Oct 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37977

FORM 8-K

Filing date
27 Sep 2017
Reporting date
25 Sep 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
25 Sep 2017
Reporting date
21 Sep 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
15 Sep 2017
Reporting date
12 Sep 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .